Interaction between behavioral despair and addictive behaviors in rats

被引:9
作者
Tian, Meng [1 ,3 ]
Mao, Rong-Rong [1 ]
Wang, Li-Ping [1 ]
Zhou, Qi-Xin [1 ]
Cao, Jun [1 ]
Xu, Lin [1 ,2 ]
机构
[1] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China
[2] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha 410011, Hunan, Peoples R China
[3] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China
基金
美国国家科学基金会;
关键词
Behavioral despair; Addictive behavior; Conditioned place preference; Forced swim test; Morphine; FORCED SWIMMING TEST; DORSAL RAPHE NUCLEUS; EXTRACELLULAR SEROTONIN; ANTIDEPRESSANT TREATMENTS; LOCOMOTOR-ACTIVITY; FRONTAL-CORTEX; OPIOID SYSTEM; 5-HT LEVELS; MORPHINE; DEPRESSION;
D O I
10.1016/j.physbeh.2010.10.002
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
It has been suggested that depression can be either a cause or a consequence of drug abuse, providing a possible explanation for the fact that the prevalence of depression is almost 3-fold higher in drug abusers than in the general population. However, the interaction between depression and drug abuse has not been fully elucidated. To examine the interaction between behavioral despair and addictive behaviors, we used the Porsolt's forced swim test (FST) as a model of behavioral despair, and we used morphine conditioned place preference (CPP) and repeated morphine exposure as models of addictive behaviors. We found that rats exposed to a standard FST (15 min on day 0 training) rather than a weak FST (10 min on day 0 training) exhibited behavioral despair, which selectively potentiated morphine CPP (mCPP) but not food CPP (fCPP). The antidepressant imipramine (15 mg/kg, i.p.), which blocked the behavioral despair, prevented the standard FST potentiated morphine CPP. Conversely, repeated exposure to morphine (10 mg/kg, s.c.) for 6, 12 or 20 days decreased, had no effect on, or increased the immobility time, respectively, in the subsequent standard FST. Furthermore, repeated morphine exposure for 20 days exacerbated the pre-existing behavioral despair. Thus, our findings suggest that behavioral despair may increase the vulnerability of individuals to opiate abuse, which may in turn enhance behavioral despair. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 42 条
  • [11] Depression and the severity of substance abuse
    Coelho, R
    Rangel, R
    Ramos, E
    Martins, A
    Prata, J
    Barros, H
    [J]. PSYCHOPATHOLOGY, 2000, 33 (03) : 103 - 109
  • [12] Morphine conditioned place preference depends on glucocorticoid receptors in both hippocampus and nucleus accumbens
    Dong, Zhifang
    Han, Huili
    Wang, Meina
    Xu, Lin
    Hao, Wei
    Cao, Jun
    [J]. HIPPOCAMPUS, 2006, 16 (10) : 809 - 813
  • [13] Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors
    Dreshfield, LJ
    Wong, DT
    Perry, KW
    Engleman, EA
    [J]. NEUROCHEMICAL RESEARCH, 1996, 21 (05) : 557 - 562
  • [14] FILIBECK U, 1980, POL J PHARMACOL PHAR, V32, P149
  • [15] Gobert A, 1997, J NEUROCHEM, V68, P1159
  • [16] Pharmacokinetic differences of morphine and morphine-glucuronides are reflected in locomotor activity
    Handal, M
    Grung, M
    Skurtveit, S
    Ripel, Å
    Morland, J
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 73 (04) : 883 - 892
  • [17] Effect of olivocochlear bundle lesion on locomotor activity in rats
    Hsieh, YL
    Chen, TJ
    Lin, CH
    Chen, SS
    [J]. PHYSIOLOGY & BEHAVIOR, 1998, 64 (02) : 179 - 184
  • [18] EFFECTS OF ILLUMINATION AND HANDLING UPON RAT OPEN-FIELD ACTIVITY
    IGARASHI, E
    TAKESHITA, S
    [J]. PHYSIOLOGY & BEHAVIOR, 1995, 57 (04) : 699 - 703
  • [19] Jolas T, 2000, NEUROSCIENCE, V95, P433
  • [20] Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice:: Assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical data
    Kalvass, J. Cory
    Olson, Emily R.
    Cassidy, Michael P.
    Selley, Dana E.
    Pollack, Gary M.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 323 (01) : 346 - 355